Hormonal Substrate Bioavailability is the measure of the concentration of essential precursor molecules and cofactors that are readily available to the endocrine glands and target tissues for the synthesis and action of hormones. This concept recognizes that sufficient hormone production relies not only on glandular health but also on the systemic availability of foundational building blocks, such as cholesterol and specific vitamins or minerals. Optimizing bioavailability is a key step before considering exogenous hormone administration.
Origin
This term is deeply rooted in biochemistry and nutritional science, specifically focusing on the initial steps of the steroidogenesis pathway. ‘Substrate’ refers to the raw material, and ‘Bioavailability’ is a pharmaceutical term adapted to describe the proportion of the substrate that enters the circulation and is available to exert an effect. It is a fundamental consideration in functional endocrinology.
Mechanism
The mechanism involves ensuring optimal absorption, transport, and enzymatic conversion of precursors into active hormones. For example, sufficient cholesterol is needed for all steroid hormones, while certain B vitamins and zinc are critical cofactors for various enzyme steps in the cascade. When substrate bioavailability is compromised, the endocrine system cannot synthesize hormones effectively, leading to functional deficiencies even with seemingly healthy glands.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.